Skip to content

Senti Biosciences Holdings, Inc.

SNTI

CIK 0001854270

← back to feed
Revenue (TTM)
$16K
Q1 Apr 2026
Net Income (TTM)
−$51.19M
−16.4% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$2.80
+77.3% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-342,243.8%
Q1 Apr 2026
Net Margin
-319,950.0%
Q1 Apr 2026
Free Cash Flow (TTM)
−$63.42M
Q1 Apr 2026
Cash
$8.94M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
31.14M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings